Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Dye

Showing results (21-30 of 154) with videos related to

Pageof 16
Sort By:
Nature Communications|September 16, 2024
Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine designSurender Khurana, Gabrielle Grubbs, Supriya Ravichandran, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2011
A nonreplicating subunit vaccine protects mice against lethal Ebola virus challengeWaranyoo Phoolcharoen, John M Dye, Jacquelyn Kilbourne, et al.
Antiviral Research|November 2, 2020
BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antiviralsSzuyuan Pu, Stanford Schor, Marwah Karim, et al.
Tropical Diseases, Travel Medicine and Vaccines|December 5, 2019
Dengue fever and chikungunya virus infections: identification in travelers in Uganda - 2017John T Kayiwa, Annet M Nankya, Irene Ataliba, et al.
Cell Host & Microbe|February 14, 2020
Longitudinal Human Antibody Repertoire against Complete Viral Proteome from Ebola Virus Survivor Reveals Protective Sites for Vaccine DesignSurender Khurana, Supriya Ravichandran, Megan Hahn, et al.
RSC Medicinal Chemistry|November 15, 2021
A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): <i>in silico</i> and <i>in vitro</i> investigationsSumit Kumar, Yash Gupta, Samantha E Zak, et al.
Clinical and Vaccine Immunology : CVI|June 24, 2016
Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody ResponsesMohan Natesan, Stig M Jensen, Sarah L Keasey, et al.
The Journal of Infectious Diseases|August 27, 2021
Characterization of an Anti-Ebola Virus Hyperimmune Globulin Derived From Convalescent PlasmaJonathan M Ciencewicki, Andrew S Herbert, Nadia Storm, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2012
Postexposure antibody prophylaxis protects nonhuman primates from filovirus diseaseJohn M Dye, Andrew S Herbert, Ana I Kuehne, et al.
The Journal of Biological Chemistry|March 4, 2018
Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteinsElisabeth K Nyakatura, Samantha E Zak, Anna Z Wec, et al.
Pageof 16

Showing results (21-30 of 154) with videos related to

Sort By:
Pageof 16
Nature Communications|September 16, 2024
Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine designSurender Khurana, Gabrielle Grubbs, Supriya Ravichandran, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2011
A nonreplicating subunit vaccine protects mice against lethal Ebola virus challengeWaranyoo Phoolcharoen, John M Dye, Jacquelyn Kilbourne, et al.
Antiviral Research|November 2, 2020
BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antiviralsSzuyuan Pu, Stanford Schor, Marwah Karim, et al.
Tropical Diseases, Travel Medicine and Vaccines|December 5, 2019
Dengue fever and chikungunya virus infections: identification in travelers in Uganda - 2017John T Kayiwa, Annet M Nankya, Irene Ataliba, et al.
Cell Host & Microbe|February 14, 2020
Longitudinal Human Antibody Repertoire against Complete Viral Proteome from Ebola Virus Survivor Reveals Protective Sites for Vaccine DesignSurender Khurana, Supriya Ravichandran, Megan Hahn, et al.
RSC Medicinal Chemistry|November 15, 2021
A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): <i>in silico</i> and <i>in vitro</i> investigationsSumit Kumar, Yash Gupta, Samantha E Zak, et al.
Clinical and Vaccine Immunology : CVI|June 24, 2016
Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody ResponsesMohan Natesan, Stig M Jensen, Sarah L Keasey, et al.
The Journal of Infectious Diseases|August 27, 2021
Characterization of an Anti-Ebola Virus Hyperimmune Globulin Derived From Convalescent PlasmaJonathan M Ciencewicki, Andrew S Herbert, Nadia Storm, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2012
Postexposure antibody prophylaxis protects nonhuman primates from filovirus diseaseJohn M Dye, Andrew S Herbert, Ana I Kuehne, et al.
The Journal of Biological Chemistry|March 4, 2018
Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteinsElisabeth K Nyakatura, Samantha E Zak, Anna Z Wec, et al.
Pageof 16